Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
NCT05988710Phase 4Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2023
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine in pain, sponsored by Vanderbilt University Medical Center. Started Oct 2023; status: recruiting.
02
Drugs
buprenorphine
03
Conditions
pain
Beyond the preview
Go deeper on NCT05988710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05988710.